uniQure to Announce First Quarter 2026 Financial Results
Rhea-AI Summary
uniQure (NASDAQ: QURE) will report first quarter 2026 financial results before market open on Tuesday, May 5, 2026. Management will host a conference call at 8:30 a.m. ET the same day. The live webcast and a 90-day replay will be available in the Events & Presentations section of the company website.
Analysts may access the live call by dialing the provided numbers and entering conference ID 4607289. Participants are asked to join 15 minutes before start time.
Positive
- None.
Negative
- None.
News Market Reaction – QURE
In the Apr 28 session, QURE gained 0.84%, reflecting a mild positive market reaction. Argus tracked a trough of -11.4% from its starting point during tracking. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | Earnings date notice | Neutral | +4.4% | Announced timing of 2025 year-end results and accompanying conference call. |
| Nov 06 | Earnings date notice | Neutral | +5.6% | Set date and call details for Q3 2025 financial results release. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date announcements for QURE were followed by mid-single-digit positive moves on the day of release.
Recent history shows QURE using similar announcements to schedule quarterly financial results and calls. The last two earnings date releases on Nov 06, 2025 and Feb 23, 2026 preceded third-quarter 2025 and full-year 2025 earnings, respectively, and were followed by share moves of +5.56% and +4.42%. Today’s first-quarter 2026 earnings date notice continues this pattern of routine calendar communication ahead of detailed financial and pipeline updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
~ uniQure to host earnings call on Tuesday, May 5, 2026 at 8:30 a.m. ET ~
LEXINGTON, Mass. and AMSTERDAM, April 28, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2026 financial results before market open on Tuesday, May 5, 2026. Management will then host a conference call at 8:30 a.m. ET.
The event will be webcast under the Events & Presentations section of uniQure’s website at https://www.uniqure.com/investors-media/events-presentations, and following the event a replay will be archived for 90 days. Analysts wishing to participate in the question and answer session should access the live call by dialing (646) 307-1963 or toll-free (800) 715-9871 and entering conference ID 4607289. If you are joining the conference call, please join 15 minutes before the start time.
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. The approvals of uniQure’s gene therapy for hemophilia B – an historic achievement based on more than a decade of research and clinical development – represent a major milestone in the field of genomic medicine and ushers in a new treatment approach for patients living with hemophilia. uniQure is now advancing a pipeline of proprietary gene therapies for the treatment of patients with Huntington's disease, refractory temporal lobe epilepsy, Fabry disease, and other severe diseases. www.uniQure.com
uniQure Contacts:
| FOR INVESTORS: | FOR MEDIA: | |
| Chiara Russo | Tom Malone | |
| Direct: 781-491-4371 | Direct: 339-970-7558 | |
| Mobile: 617-306-9137 | Mobile:339-223-8541 | |
| c.russo@uniQure.com | t.malone@uniQure.com |
